Schedule 13D ownership disclosure
CARISMA THERAPEUTICS INC
Common Stock, par value $0.001 per share · CUSIP: 14216R101
Event date: 2025-08-19
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- HealthCap VII, L.P.Reported CIK 0001645161
Shares: 2,721,923.00 · Class: 6.5%
- HealthCap VII GP LLC
Shares: 2,721,923.00 · Class: 6.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-079448
- Form type
- SCHEDULE 13D/A
- Filer
- Carisma Therapeutics Inc.
- CIK
- CIK 1485003
- Filed
- Aug 21, 2025
- Reporting period
- Aug 19, 2025
- Description
- Schedule 13D beneficial ownership